Association of Triglyceride-Glucose Body Mass Index with Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study
- PMID: 40751457
- PMCID: PMC12317321
- DOI: 10.1111/jch.70114
Association of Triglyceride-Glucose Body Mass Index with Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study
Abstract
The triglyceride-glucose body mass index (TyG-BMI) is an emerging composite metabolic indicator in cardiovascular research. However, the link between TyG-BMI and target organ damage (TOD) in essential hypertension (EH) remains uncertain. This study investigated the association between TyG-BMI and TOD in patients with EH. We conducted a retrospective cohort study involving 493 individuals with EH. Participants were divided at the cohort-specific median into high and low TyG-BMI groups. Over a median follow-up of 23 months, 191 participants experienced TOD. Kaplan-Meier curves showed a significantly higher cumulative incidence of TOD in the high TyG-BMI group than in the low TyG-BMI group (p < 0.05). In multivariable logistic regression, TyG-BMI remained an independent correlate of TOD (adjusted OR = 1.83, 95% CI: 1.08-3.10; p < 0.05). Least absolute shrinkage and selection operator-Cox regression further selected TyG-BMI, age, and smoking status as key predictors of TOD. Subgroup analyses revealed that the TyG-BMI-TOD association was stronger among younger or middle-aged, normal-weight, non-diabetic, non-smoking subjects (p < 0.05). Finally, the TyG-BMI-based model achieved predictive accuracy comparable to that of a conventional risk-factor model. In conclusion, TyG-BMI is independently associated with TOD in EH patients. Its predictive value closely mirrors that of combined traditional risk factors, highlighting TyG-BMI as a promising clinical marker.
Keywords: hypertension; insulin resistance; target organ damage; triglyceride–glucose body mass index.
© 2025 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Zhang W., Zhang S., Deng Y., et al., “Trial of Intensive Blood Pressure Control in Older Patients With Hypertension,” New England Journal of Medicine 385, no. 14 (2021): 1268–1279. - PubMed
-
- Cai Z., Gong Z., Li Z., Li L., and Kong W., “Vascular Extracellular Matrix Remodeling and Hypertension,” Antioxid Redox Signaling 34, no. 10 (2021): 765–783. - PubMed
-
- Wong N. D. and Sattar N., “Cardiovascular Risk in Diabetes Mellitus: Epidemiology, Assessment and Prevention,” Nature Reviews Cardiology 20, no. 10 (2023): 685–695. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
